0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Adverse Drug Effects
 21-40 of 840 Articles
JAMA Psychiatry | 
Original Investigation |  ONLINE FIRST
Britta Galling, MD; Alexandra Roldán, MD; René E. Nielsen, MD, PhD; et al.
JAMA Psychiatry. Published online January 20, 2016. doi:10.1001/jamapsychiatry.2015.2923
Includes: Supplemental Content

JAMA | 
News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;315(3):243. doi:10.1001/jama.2015.18375.

JAMA | 
News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;315(3):243. doi:10.1001/jama.2015.18729.

JAMA Internal Medicine | 
Challenges in Clinical Electrocardiography |  ONLINE FIRST
Sharana Hegde, MBBS; Vineet Kumar, MD
JAMA Intern Med. Published online January 19, 2016. doi:10.1001/jamainternmed.2015.7605

JAMA Oncology | 
Editorial | 
Gérard Milano, PhD; Emmanuel Chamorey, PharmD, PhD; Jean-Marc Ferrero, MD, PhD
JAMA Oncol. 2016;2(1):21-22. doi:10.1001/jamaoncol.2015.3866.

JAMA Oncology | 
Original Investigation | 
Chau Dang, MD; Hao Guo, MS; Julie Najita, PhD; et al.
JAMA Oncol. 2016;2(1):29-36. doi:10.1001/jamaoncol.2015.3709.
Includes: Supplemental Content

JAMA Internal Medicine | 
Invited Commentary | 
Chester B. Good, MD, MPH; Walid F. Gellad, MD, MPH
JAMA Intern Med. 2016;176(1):63-64. doi:10.1001/jamainternmed.2015.6068.

JAMA Internal Medicine | 
Original Investigation | 
Tewodros Eguale, MD, PhD; David L. Buckeridge, MD, PhD; Aman Verma, PhD; et al.
JAMA Intern Med. 2016;176(1):55-63. doi:10.1001/jamainternmed.2015.6058.
Includes: Supplemental Content

JAMA Internal Medicine | 
Teachable Moment | 
Nathan Handley, MD; Alon Unger, MD
JAMA Intern Med. 2016;176(1):19-20. doi:10.1001/jamainternmed.2015.6527.

JAMA Dermatology | 
Original Investigation | 
Young H. Lee, MD; Thomas P. Scharnitz, BS; Joshua Muscat, PhD; et al.
JAMA Dermatol. 2016;152(1):35-44. doi:10.1001/jamadermatol.2015.3091.
Includes: Supplemental Content

JAMA Internal Medicine | 
Research Letter | 
Alberto Maino, MD; Bob Siegerink, PhD; Ale Algra, MD, PhD; et al.
JAMA Intern Med. 2016;176(1):134-136. doi:10.1001/jamainternmed.2015.6523.

JAMA Dermatology | 
Editorial | 
Kanade Shinkai, MD, PhD; Amy McMichael, MD; Eleni Linos, MD, MPH, DrPH
JAMA Dermatol. 2016;152(1):17-19. doi:10.1001/jamadermatol.2015.3128.

JAMA Internal Medicine | 
Viewpoint | 
Anna Hung, PharmD; Jan Sieluk, MPharm; Peter Doshi, PhD
JAMA Intern Med. 2016;176(1):11-12. doi:10.1001/jamainternmed.2015.6656.

JAMA Oncology | 
Invited Commentary | 
Kutluk Oktay, MD, PhD; Volkan Turan, MD
JAMA Oncol. 2016;2(1):74-75. doi:10.1001/jamaoncol.2015.3252.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation | 
Rodrigo R. Munhoz, MD; Allan A. L. Pereira, MD; André D. Sasse, MD; et al.
JAMA Oncol. 2016;2(1):65-73. doi:10.1001/jamaoncol.2015.3251.
Includes: CME

JAMA Dermatology | 
Observation | 
Ander Mayor-Ibarguren, MD; María Concepción Roldán-Puchalt, MD; Cristina Gómez-Fernández, MD; et al.
JAMA Dermatol. 2016;152(1):109-111. doi:10.1001/jamadermatol.2015.2702.

JAMA Oncology | 
Brief Report | 
Dickran Kazandjian, MD; Sean Khozin, MD, MPH; Gideon Blumenthal, MD; et al.
JAMA Oncol. 2016;2(1):118-122. doi:10.1001/jamaoncol.2015.3934.

JAMA Dermatology | 
Original Investigation | 
Camille Hua, MD; Lise Boussemart, MD, PhD; Christine Mateus, MD; et al.
JAMA Dermatol. 2016;152(1):45-51. doi:10.1001/jamadermatol.2015.2707.
Includes: Supplemental Content

JAMA Dermatology | 
Observation |  ONLINE FIRST
Olivia Leigh Quach, MD; Sylvia Hsu, MD
JAMA Dermatol. Published online December 30, 2015. doi:10.1001/jamadermatol.2015.4992

JAMA Oncology | 
Editorial |  ONLINE FIRST
Michael Kolinsky, BSc, MD; Pasquale Rescigno, MD; Johann S. de Bono, MB, ChB, MSc, FRCP, PhD, FMedSci
JAMA Oncol. Published online December 23, 2015. doi:10.1001/jamaoncol.2015.4918

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Ophthalmology
Observation  | 
Central Retinal Vein Occlusion Noted 2 Days After Use of Phendimetrazine as an Appetite Suppressant
Ah Ran Cho, MD; Young Hee Yoon, MD
JAMA Oncology
Brief Report  | 
Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian Carcinoma
Elizabeth M. Swisher, MD; Maria I. Harrell, PhD; Barbara M. Norquist, MD; et al.
JAMA Oncology
Original Investigation  | 
Association Between BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia and Cardiovascular Events, Major Molecular Response, and Overall Survival A Systematic Review and Meta-analysis
Jonathan Douxfils, PharmD, PhD; Hélène Haguet, MBS; François Mullier, PharmD, PhD; et al.
JAMA Oncology
Review  | 
Toxic Effects of Sorafenib in Patients With Differentiated Thyroid Carcinoma Compared With Other Cancers
Gary W. Jean, PharmD; Rene M. Mani, PharmD; Aliza Jaffry, PharmD; et al.